Jenburkt Pharmaceuticals Limited share price

Key numbers

Market cap

-

Current price

₹ 948.00

52-week high / low

₹ 1,074 / 930

Stock P/E

12.7

Book value

₹ 446.5

Dividend yield

2.18%

ROCE

25.0%

ROE

18.8%

Debt to equity

0.01

Sales growth (3 yrs)

7.3%

Profit growth (3 yrs)

12.2%

1-year return

-

About Jenburkt Pharmaceuticals Limited

Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. It offers its products under the Allerzine, CartiSafe Forte, Crisbo, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, and Zydol Suspension brand names. The company also exports its products. It serves large government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.

Quarterly results

Consolidated figures in ₹ crores

Peers in Drug Manufacturers - Specialty & Generic

• Sun Pharmaceutical Industries Limited
• Divi's Laboratories Limited
• Torrent Pharmaceuticals Limited
• Zydus Lifesciences Limited
• Cipla Limited
• Laurus Labs Limited
• Mankind Pharma Limited
• Dr. Reddy's Laboratories Limited
• Aurobindo Pharma Limited
• Lupin Limited